[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341318-105":59,"doc-detail-341318-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","systematic-analysis-of-igf2bp-family-members-in-non-small-cell-lung-cancer","Systematic analysis of IGF2BP family members in non-small-cell lung cancer","","Insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1/2/3) are linked to tumorigenesis, metastasis, prognosis, and cancer immunity across cancers, yet NSCLC studies often overlook lung squamous cell carcinoma (LUSC). This work compares IGF2BP family differential expression in tumors versus normal tissues and performs meta-analyses in LUAD and LUSC. It evaluates immune infiltration, mutation features, chemotherapy sensitivity, tumor mutation burden, and uses GSEA to define associated pathways. Results show IGF2BP2/3 upregulation in LUSC and distinct prognostic and pathway patterns between LUAD and LUSC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-analysis-of-igf2bp-family-members-in-non-small-cell-lung-cancer/341318/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-analysis-of-igf2bp-family-members-in-non-small-cell-lung-cancer/341318.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main aim of this systematic analysis?","Question",{"text":113,"@type":114},"To characterize how IGF2BP family members differ in non-small-cell lung cancer, with particular focus on lung squamous cell carcinoma (LUSC), and to assess their prognostic and biological relevance in comparison with lung adenocarcinoma (LUAD).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which IGF2BP members show increased expression in LUSC?",{"text":118,"@type":114},"IGF2BP2 and IGF2BP3 are reported as upregulated in LUSC patients.",{"name":120,"@type":111,"acceptedAnswer":121},"How do prognostic associations differ between LUAD and LUSC?",{"text":122,"@type":114},"Meta-analyses show a significant negative correlation between overall survival (OS) and IGF2BP2/3 expression in LUAD patients, but not in LUSC patients.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341318,1790192814,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Gong et al. Human Genomics (2024) 18:63 Human Genomics  \n[https://doi.org/10.1186/s40246-024-00632-6](https://doi.org/10.1186/s40246-024-00632-6)  \nRESEARCH Open Access  \nSystematic analysis of IGF2BP family members in non-small-cell lung cancer  \nLiping Gong 1, Qin Liu2, Ming Jia2 and Xifeng Sun3*  \nAbstract  \nBackground The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1, IGF2BP2, and IGF2BP3) are known to be involved in tumorigenesis, metastasis, prognosis, and cancer immunity in various human cancers, including non-small cell lung cancer (NSCLC) . However, the literature on NSCLC largely omits the specific context of lung squamous cell carcinoma (LUSC), an oversight we aim to address.  \nMethods Our study evaluated the differential expression of IGF2BP family members in tumors and normal tissues. Meta-analyses were conducted to assess the prognostic value of IGF2BPs in lung adenocarcinoma (LUAD) and LUSC. Additionally, correlations between IGF2BPs and tumor immune cell infiltration, mutation characteristics, chemotherapy sensitivity, and tumor mutation burden (TMB) were investigated. GSEA was utilized to delineate biological processes and pathways associated with IGF2BPs.  \nResults IGF2BP2 and IGF2BP3 expression were found to be upregulated in LUSC patients. IGF2BP2 mRNA levels were correlated with cancer immunity in both LUSC and LUAD patients. A higher frequency of gene mutations was observed in different IGF2BP1/2/3 expression groups in LUAD compared to LUSC. Meta-analyses revealed a significant negative correlation between overall survival (OS) and IGF2BP2/3 expression in LUAD patients but not in LUSC patients. GSEA indicated a positive association between VEGF and IGF2BP family genes in LUAD, while matrix metal lopeptidase activity was inversely correlated with IGF2BP family genes in LUSC. Several chemotherapy drugs showed significantly lower IC50 values in high IGF2BP expression groups in both LUAD and LUSC.  \nConclusion Our findings indicated that IGF2BPs play different roles in LUAD and LUSC. This divergence highlights the need for tailored therapeutic strategies and prognostic tools, cognizant of the unique molecular profiles of LUAD and LUSC.  \nKeywords IGF2BP, NSCLC, Survival, Cancer immunity, Meta-analysis  \n*Correspondence: Xifeng Sun [xifengs@163.com](xifengs@163.com)  \n1Department of Academic Research, The Secondary Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, China 2Department of Cancer Center, The Secondary Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, China  \n3Institute of Medical Sciences, The Secondary Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Jinan, Shandong 250033, P. R. China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nGong et al. Human Genomics (2024) 18:63  \nIntroduction  \nIn","cbCaisOOsVpYPkQC","https://ap.wps.com/l/cbCaisOOsVpYPkQC","pdf",14491917,"English","# Introduction\n## Background and rationale\n# Methods\n## Differential expression and meta-analysis\n## Immune infiltration, mutation traits, chemotherapy sensitivity, and TMB\n## GSEA\n# Results\n## Expression differences in LUAD vs LUSC\n## Associations with immunity, survival, and pathways\n## Chemotherapy sensitivity and IC50 patterns\n# Conclusion","[{\"question\":\"What is the main aim of this systematic analysis?\",\"answer\":\"To characterize how IGF2BP family members differ in non-small-cell lung cancer, with particular focus on lung squamous cell carcinoma (LUSC), and to assess their prognostic and biological relevance in comparison with lung adenocarcinoma (LUAD).\"},{\"question\":\"Which IGF2BP members show increased expression in LUSC?\",\"answer\":\"IGF2BP2 and IGF2BP3 are reported as upregulated in LUSC patients.\"},{\"question\":\"How do prognostic associations differ between LUAD and LUSC?\",\"answer\":\"Meta-analyses show a significant negative correlation between overall survival (OS) and IGF2BP2/3 expression in LUAD patients, but not in LUSC patients.\"}]","Systematic analysis of IGF2BP family members in non-small-cell lung cancer | PDF",1790041506,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02e62f58dc87f5275409b999c45f2e4b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cdebb36d072d43909dab3f272f45d4f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/753a3f23a14b38570f552158193e08f1.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f585e59a9add415bcb606e1807cd2d7.webp",980,1306]